Michael Verlander is technical advisor at PolyPeptide Group.
Control Strategies for Synthetic Therapeutic Peptide APIs Part II: Raw Material Considerations
USP evaluates raw materials used in the chemical synthesis of peptides.
Control Strategies for Synthetic Therapeutic Peptide APIs— Part I: Analytical Consideration
USP evaluates quality attributes for synthetic peptides.